The most recent guidance advises that routine screening is appropriate for those who believe that they were exposed to stilbestrol in utero, and we would encourage all women to attend their routine breast and cervical screening appointments.In line with the UK NSC’s current recommendations, all women aged between 50 to 70 are invited for breast screening every three years.